GlassScriptPhysician profile
Audelia Eben
NPI 1942905583
$2,552.37
in general payments reported to CMS, 2019-2025
17 companies · $1,869 in 2025
The $1,869 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $683 · 2025: $1,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,528 · Education: $24.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,528.20 |
| Education | $24.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $357.66 | 2025 | Tremfya |
| Abbvie INC. | $322.00 | 2025 | |
| Lilly USA, LLC | $301.19 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Genzyme Corporation | $212.60 | 2024-2025 | |
| Incyte Corporation | $206.78 | 2024-2025 | Opzelura |
| Ucb, INC. | $186.78 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $180.37 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $174.26 | 2024-2025 | Dupixent |
| Galderma Laboratories, L.P. | $147.18 | 2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $110.87 | 2024-2025 | Sotyktu |
| Journey Medical Corporation | $97.33 | 2025 | |
| Amgen INC. | $93.43 | 2024-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $47.69 | 2024 | Zoryve |
| Biofrontera INC. | $38.98 | 2025 | Bf-Rhodoled, Ameluz, Rhodoled Xl |
| Organon LLC | $32.37 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.25 | 2024 | Spevigo |
| Genentech USA, INC. | $16.63 | 2024 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audelia Eben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.